Bilal F., Montfort A., Gilhodes J., Garcia V., Riond J., Carpentier S.,Filleron T., Colacios C., Levade T., Daher A., Meyer N., Andrieu Abadie N., Ségui B. Sphingomyelin synthase 1 (SMS1) downregulationis associated with sphingolipid reprogramming and aworse prognosis in melanoma. This evidence concerns the gene SGMS1 and melanoma.